SCA Global is a worldwide initiative for clinical research in spinocerebellar ataxias. Redenlab founder Adam Vogel will be presenting “Speech as a biomarker in ataxia: What can it tell us and how should we use it?”
SCA & ARCA Global Conference 2020, 19-21 October 2020
